JP2519148B2 - うつ病治療剤 - Google Patents

うつ病治療剤

Info

Publication number
JP2519148B2
JP2519148B2 JP3346474A JP34647491A JP2519148B2 JP 2519148 B2 JP2519148 B2 JP 2519148B2 JP 3346474 A JP3346474 A JP 3346474A JP 34647491 A JP34647491 A JP 34647491A JP 2519148 B2 JP2519148 B2 JP 2519148B2
Authority
JP
Japan
Prior art keywords
adenine dinucleotide
nicotinamide adenine
treatment
depression
patients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP3346474A
Other languages
English (en)
Japanese (ja)
Other versions
JPH05139978A (ja
Inventor
ビルクマイヤー ユルク
ビルクマイヤー ヴァルター
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JPH05139978A publication Critical patent/JPH05139978A/ja
Application granted granted Critical
Publication of JP2519148B2 publication Critical patent/JP2519148B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
JP3346474A 1991-01-04 1991-12-27 うつ病治療剤 Expired - Fee Related JP2519148B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4100361A DE4100361C1 (de) 1991-01-04 1991-01-04
DE4100361.6 1991-01-04

Publications (2)

Publication Number Publication Date
JPH05139978A JPH05139978A (ja) 1993-06-08
JP2519148B2 true JP2519148B2 (ja) 1996-07-31

Family

ID=6422686

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3346474A Expired - Fee Related JP2519148B2 (ja) 1991-01-04 1991-12-27 うつ病治療剤

Country Status (15)

Country Link
EP (1) EP0493861B1 (de)
JP (1) JP2519148B2 (de)
AT (1) ATE148991T1 (de)
AU (1) AU631755B2 (de)
BR (1) BR9105183A (de)
CA (1) CA2057456C (de)
DE (2) DE4100361C1 (de)
DK (1) DK0493861T3 (de)
ES (1) ES2097181T3 (de)
GR (1) GR3022724T3 (de)
HU (1) HU213112B (de)
IE (1) IE914477A1 (de)
NO (1) NO179602C (de)
PT (1) PT99962B (de)
ZA (1) ZA9244B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2735293A1 (en) * 1995-01-17 1996-07-18 Menuco Corp. Nadh and nadph therapeutic agents for dermal administration
US5712259A (en) * 1996-04-22 1998-01-27 Birkmayer Pharmaceuticals NADH and NADPH pharmaceuticals for treating chronic fatigue syndrome
US5668114A (en) * 1996-05-08 1997-09-16 Birkmayer Pharmaceuticals NADH and NADPH pharmaceuticals for treating hypertension
ES2953842A1 (es) * 2023-07-17 2023-11-16 Nuadi Europe S L Tapacubos antipolvo

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3341412A (en) * 1966-03-04 1967-09-12 Enzomedic Lab Inc Methods of treating schizophrenia
US4970200A (en) * 1988-03-01 1990-11-13 Schering Aktiengesellschaft Agent for treatment of Parkinson's disease

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
THE MERCK INDEX 11TH ED=1989 *

Also Published As

Publication number Publication date
CA2057456A1 (en) 1992-07-05
DE4100361C1 (de) 1992-04-23
CA2057456C (en) 1996-02-06
NO179602B (no) 1996-08-05
DK0493861T3 (da) 1997-08-25
JPH05139978A (ja) 1993-06-08
EP0493861B1 (de) 1997-02-19
HUT60141A (en) 1992-08-28
ATE148991T1 (de) 1997-03-15
ES2097181T3 (es) 1997-04-01
BR9105183A (pt) 1992-09-29
DE59108553D1 (de) 1997-03-27
IE914477A1 (en) 1992-07-15
NO179602C (no) 1996-11-13
HU9200025D0 (en) 1992-03-30
NO920056L (no) 1992-07-06
EP0493861A3 (en) 1993-03-03
PT99962A (pt) 1993-02-26
HU213112B (en) 1997-02-28
ZA9244B (en) 1992-10-28
GR3022724T3 (en) 1997-06-30
EP0493861A2 (de) 1992-07-08
PT99962B (pt) 1999-06-30
AU9010991A (en) 1992-07-16
AU631755B2 (en) 1992-12-03
NO920056D0 (no) 1992-01-03

Similar Documents

Publication Publication Date Title
Gualtieri Pharmacotherapy and the neurobehavioural sequelae of traumatic brain injury
SWEET et al. Mental symptoms in Parkinson's disease during chronic treatment with levodopa
US20060252761A1 (en) Augmentation of extinction via administration of sub-antimicrobial doses of D-cycloserine
US20210236523A1 (en) Psychedelic treatment for headache disorders
JPH0380127B2 (de)
JPH02240021A (ja) 抑うつ障害の治療用に適した制御放出製薬組成物
Fenelon et al. Efficacy and tolerability of entacapone in patients with Parkinson's disease treated with levodopa plus a dopamine agonist and experiencing wearing-off motor fluctuations. A randomized, double-blind, multicentre study
Wålinder et al. 5‐HT reuptake inhibitors plus tryptophan in endogenous depression
JPH0227327B2 (de)
JPH07116048B2 (ja) パーキンソン症候群の治療用薬剤
JP2519148B2 (ja) うつ病治療剤
AU2007259256A1 (en) Combination preparations comprising bifeprunox and L-DOPA
US20070292536A1 (en) Composition and method for treating patients with high neurotransmitter levels
Birkmayer et al. Nicotinamidadenindinucleotide (NADH): the new approach in the therapy of Parkinson's disease
US7915262B2 (en) Combination preparations comprising SLV308 and a dopamine agonist
PT98628A (pt) Processo de composicoes farmaceuticas a base de por exemplo sertralina
US20230255882A1 (en) Long-lasting resorbable subcutaneous implant with sustained release of pre-concentrated pharmacologically active substance in polymer for the treatment of parkinsons disease
JP5880913B2 (ja) パーキンソン病の体幹症状（姿勢反射異常）の治療剤
WO2008010768A1 (en) Method of treating and diagnosing restless legs syndrome and periodic limb movements during sleep and means for carrying out the method
US20090304816A1 (en) Method and composition for treating and diagnosing restless legs syndrome
EP2035002A1 (de) Kombinationspräparate mit slv308 und einem l-dopa
Rabey et al. EEG sleep study in Parkinsonian patients under bromocryptine treatment
JP2002531417A (ja) 追加的な局所麻酔薬を含むパーキンソン病の症候を処置する薬剤
US8106056B2 (en) Combination preparations comprising bifeprunox and a dopamine agonist
RU2188630C1 (ru) Средство профилактики и лечения наркомании

Legal Events

Date Code Title Description
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 19960130

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees